PXB-SHIZUKU
LIVE

Serial Number

79378897

Owner

PhoenixBio Co., Ltd.

Attorney

Jeffrey H. Handelsman

Filing Date

Jul 25, 2023

Add to watchlist:

No watchlists yet
View on USPTO

PXB-SHIZUKU Trademark

Serial Number: 79378897 • Registration: 7602251

PXB-SHIZUKU is a trademark filed by PhoenixBio Co., Ltd. on July 25, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

PhoenixBio Co., Ltd. (8 trademarks)

4-1, Kagamiyama 3-chome
Hiroshima-ken 7390046 , JP

Entity Type: 03

Trademark Details

Filing Date

July 25, 2023

Registration Date

December 17, 2024

Published for Opposition

October 15, 2024

Goods & Services

Pharmaceutical preparations for treatment of diabetes mellitus, liver disease treatment, surgical treatment, neurological disease treatment, dyslipidemia treatment, treatment of blood coagulation disorders, treatment of metabolic disorders of iron and copper, treatment of congenital metabolic disorders, treatment of trace element deficiency, treatment of infectious diseases for use in regenerative medicine; medicines for treatment of diabetes mellitus, liver disease treatment, surgical treatment, neurological disease treatment, dyslipidemia treatment, treatment of blood coagulation disorders, treatment of metabolic disorders of iron and copper, treatment of congenital metabolic disorders, treatment of trace element deficiency, treatment of infectious diseases for use in regenerative medicine for human purposes; medicines for treatment of diabetes mellitus, liver disease treatment, surgical treatment, neurological disease treatment, dyslipidemia treatment, treatment of blood coagulation disorders, treatment of metabolic disorders of iron and copper, treatment of congenital metabolic disorders, treatment of trace element deficiency, treatment of infectious diseases for use in regenerative medicine for veterinary purposes; cells for medical or veterinary purposes; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; cell culture medium for medical and veterinary purposes; cell culture conditioned medium for medical and veterinary purposes; supernatant of cell culture medium for medical and veterinary purposes; supernatant fluid of cell culture medium for medical and veterinary purposes

Chemicals for use in industry and science; biological preparations, other than for medical or veterinary purposes; cells for scientific and research use; cells for scientific or research use, other than for medical or veterinary purposes; cell culture medium for scientific or research use, other than for medical or veterinary use; cell culture conditioned medium for scientific or research use, other than for medical or veterinary purposes; supernatant of cell culture medium for scientific or research use, other than for medical or veterinary purposes; supernatant fluid of cell culture medium for scientific or research use, other than for medical or veterinary purposes

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 21, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 28, 2025 FICS
FINAL DISPOSITION PROCESSED
May 28, 2025 FIMP
NEW REPRESENTATIVE AT IB RECEIVED
Apr 25, 2025 NREP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 17, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 1, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 12, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 12, 2025 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 17, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 17, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 15, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 15, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 25, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 8, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 19, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 19, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 19, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 29, 2024 GNFN
FINAL REFUSAL E-MAILED
May 29, 2024 GNFR
FINAL REFUSAL WRITTEN
May 29, 2024 CNFR
REFUSAL PROCESSED BY IB
May 8, 2024 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 29, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 29, 2024 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 29, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 29, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 29, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 29, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 29, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 29, 2024 COAR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 17, 2024 RFCS
REFUSAL PROCESSED BY MPU
Apr 16, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 28, 2024 RFCR
NON-FINAL ACTION WRITTEN
Mar 27, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 27, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 19, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 15, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 14, 2023 REPR